AB Studio
Ab Studio Inc. is a biotechnology startup founded in 2017 in the San Francisco Bay Area, focusing on the development of complex therapeutic antibodies. The company integrates AI, machine learning, and computer-aided antibody design (CAAD) with traditional discovery methods to address challenging diseases such as cancer and infectious diseases. Ab Studio has established several patented technology platforms aimed at enhancing the efficacy, safety, and manufacturability of antibody-based therapeutics. Since 2019, the company has successfully licensed multiple bispecific antibody assets and completed over 60 partner projects, reflecting its commitment to advancing innovative therapies for significant unmet medical needs.
AB Studio
Ab Studio Inc. is a biotechnology startup founded in 2017 in the San Francisco Bay Area, focusing on the development of complex therapeutic antibodies. The company integrates AI, machine learning, and computer-aided antibody design (CAAD) with traditional discovery methods to address challenging diseases such as cancer and infectious diseases. Ab Studio has established several patented technology platforms aimed at enhancing the efficacy, safety, and manufacturability of antibody-based therapeutics. Since 2019, the company has successfully licensed multiple bispecific antibody assets and completed over 60 partner projects, reflecting its commitment to advancing innovative therapies for significant unmet medical needs.